Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
U.S. FDA Acceptance
.
Show all posts
Showing posts with label
U.S. FDA Acceptance
.
Show all posts
Monday, May 13, 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
›
In continuation of my update on lemborexant Eisai Co., Ltd. (CEO: Haruo Naito, “Eisai”) and Imbrium Therapeutics L.P. (Imbriu...
›
Home
View web version
